Erratum to: Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab

Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research